[(1S,2R,7R,9R,10R,11S,12R)-11-acetyloxy-10-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl]methyl acetate(CAS: 2270-40-8)

The compound is subject to GHS classification, REACH regulations, and FDA/EPA requirements. GHS categorizes the compound based on its health and environmental hazards, and REACH regulations require registration and risk management for substances above one tonne annually. FDA and EPA regulations govern its use in commercial and residential products.

Alternative reagents such as similar spirooxirane derivatives or other functionalized cyclohexenes can be used as substitutes. Isomers of the compound or analogs like 11-hydroxy-10-acetyloxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl]methyl acetate can also serve as viable alternatives in synthesis.

Market trends indicate increasing demand for this compound in pharmaceutical applications and advanced materials. Research is focusing on its potential in drug synthesis and as a precursor in polymer chemistry. The compound's unique properties make it a focus in emerging fields such as nanotechnology and biodegradable polymers.

Waste containing this compound should be collected, stored, and disposed of according to local regulations. Collection should be done using appropriate containers, and the waste should be incinerated or disposed of by a professional hazardous waste disposal service. Environmental protection measures include proper containment to prevent leaks and regular monitoring of the waste storage area.